Vectalys & Flashcell announce merger to create Flash Therapeutics


Vectalys & Flashcell merge and create Flash Therapeutics, a new gene therapy company.
Vectalys and FlashCell announced that they have merged to create Flash Therapeutics, a new privately held gene therapy company developing gene and cell therapeutics.
Flash Therapeutics is a new company developing proprietary RNA-based therapeutics and providing broad lentiviral development, manufacturing expertise and support.
To learn more about this new company, discover the press release in Fichier pdf English and Fichier pdf French .